Zevra Therapeutics, Inc. (ZVRA)
(Delayed Data from NSDQ)
$4.89 USD
+0.07 (1.45%)
Updated May 13, 2024 04:00 PM ET
After-Market: $4.90 +0.01 (0.20%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/12/2024
Time: -- |
6/2024 | $-0.44 | -0.76% |
Earnings Summary
For their last quarter, Zevra Therapeutics, Inc. (ZVRA) reported earnings of -$0.40 per share, beating the Zacks Consensus Estimate of $-0.49 per share. This reflects a positive earnings surprise of 18.37%. Look out for ZVRA's next earnings release expected on August 12, 2024. For the next earning release, we expect the company to report earnings of -$0.44 per share, reflecting a year-over-year decrease of 193.33%.
Earnings History
Price & Consensus
Zacks News for ZVRA
Esperion Therapeutics (ESPR) Q1 Earnings and Revenues Beat Estimates
ZVRA: What are Zacks experts saying now?
Zacks Private Portfolio Services